Wedbush analyst Laura Chico maintained a Buy rating on Ovid Therapeutics (OVID – Research Report) today and set a price target of $4.00.

Elon Musk has said ending tax credits of up to $7,500 for electric vehicle purchases would "devastate" Tesla's competitors.

Wedbush analyst David Nierengarten maintained a Buy rating on Oruka Therapeutics (ORKA – Research Report) today and set a price target of ...

Electric vehicle stocks are falling Thursday after a report detailed the incoming Trump administration’s plans to axe a tax ...

Artificial intelligence, the buzziest technology on Wall Street, was hardly a blip on the market's radar last time Donald ...

On Wednesday, Carmax Inc (KMX) stock saw a modest uptick, ending the day at $77.86 which represents a slight increase of $1.17 or 1.53% from the prior close of $76.69. The stock opened at $77.5 and ...

Nvidia (NVDA) was in focus on Thursday as several Wall Street firms upped their price targets on the semiconductor giant ahead of its fiscal third-quarter results. Read for more.

Palantir Technologies Inc. is confounding skeptics, with the stock continuing to push higher even as some on Wall Street ...

Elon Musk's ties to the Trump administration pose potential conflicts of interest for his various businesses that have ...

"It's clear that Musk will have a massive role in the Trump White House with his increasing reach clearly across many federal ...

The Tesla and X owner will lead the new "Department of Government Efficiency" with former presidential hopeful Vivek Ramaswamy.

Research analysts at Wedbush lowered their FY2025 EPS estimates for shares of Plymouth Industrial REIT in a report released ...